BIO vs CROX · rev $2.58B vs rev $4.10B
BIO (BIO) versus Crocs Inc (CROX) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
BIO currently screens at market cap $0. CROX currently screens at market cap $5.93B.
Not investment advice. Open the BIO and CROX stock pages for the full models.
Not investment advice.